Home › Cancro (tutti i tipi) › New Mexico › Albuquerque
Studi clinici su Cancro (tutti i tipi) a Albuquerque, NM
14 studi su Cancro (tutti i tipi) cercano partecipanti presso sedi a Albuquerque e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
In reclutamentoFase 3
- University of New Mexico Cancer Center, Albuquerque
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
In reclutamentoFase 2
- Lovelace Medical Center - Saint Joseph Square, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
- The University of New Mexico Comprehensive Cancer Center, Albuquerque
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
In reclutamentoFase 2
- University of New Mexico, School of Medicine, Albuquerque
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
In reclutamentoFase 1/2
- Research Site, Albuquerque
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
In reclutamentoFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Project: Every Child for Younger Patients With Cancer
In reclutamentoStudio osservazionale
- Presbyterian Hospital, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
In reclutamentoFase 3
- University of New Mexico Cancer Center, Albuquerque
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
In reclutamentoFase 2
- 292, Albuquerque
Molecular Genetics Studies of Cancer Patients and Their Relatives
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Lovelace Medical Center-Downtown, Albuquerque
- New Mexico Oncology Hematology Consultants, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
In reclutamento
- University of New Mexico Comprehensive Cancer Center, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Albuquerque
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- New Mexico Oncology Hematology Consultants, Albuquerque
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
In reclutamentoStudio osservazionale
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
In reclutamento
- Lovelace Medical Centre-Saint Joseph Square, Albuquerque
- Lovelace Women's Hospital, Albuquerque
Studi su Cancro (tutti i tipi) in altre città
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Altri studi a Albuquerque
- Cancro del polmone non a piccole cellule18 studi
- Cancro al seno17 studi
- Cancro ovarico15 studi
- Cancro ai polmoni14 studi
- Cancro dell'endometrio12 studi
- Cancro metastatico12 studi
- Diabete di tipo 211 studi
- Malattie cardiovascolari10 studi
- Cancro alla prostata9 studi
- Melanoma9 studi
- Leucemia mieloide acuta9 studi
- Malattia renale cronica8 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.